藥品檢測市場規模、佔有率和成長分析（按產品、樣品、藥物、最終用途和地區）- 產業預測 2025-2032

全球藥品檢測市場預計將在 2023 年達到 59 億美元，並從 2024 年的 62.1 億美元成長到 2032 年的 93.1 億美元，預測期內（2025-2032 年）的複合年成長率為 5.2%。

由於政府機構對解決酒精和藥物測試安全問題的監管要求不斷提高，藥物測試市場預計將經歷顯著成長。持續的監測和預防藥物成癮的努力進一步加劇了這一趨勢。此外，全球藥物濫用現象增加，加上新冠疫情對精神健康的影響，以及企業倒閉和景氣衰退，都增加了對全面篩檢解決方案的需求。這包括檢測非法藥物和處方藥物，以及運動員使用的增強體質的物質。隨著人們對此類問題的認知不斷提高，預計各種生物樣本的藥物檢測服務需求將激增，為市場擴張提供充足的機會。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

藥品檢測市場規模（依產品及複合年成長率） (2025-2032)

• 市場概況
• 耗材
• 裝置
• 快速檢測裝置
• 服務

藥品檢測市場規模（按樣本和複合年成長率） (2025-2032)

• 市場概況
• 尿液樣本
• 口腔液體樣本
• 頭髮樣本
• 其他範例

藥品檢測市場規模（依藥品類別及複合年成長率） (2025-2032)

• 市場概況
• 酒精
• 大麻
• 古柯鹼
• 鴉片類藥物
• 安非他命和甲基安非他命
• LSD（興奮劑）
• 其他

藥品檢測市場規模（依最終用途和複合年成長率） (2025-2032)

• 市場概況
• 藥品檢測實驗室
• 職場
• 醫院
• 其他

藥品檢測市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Laboratory Corporation of America Holdings（LabCorp）（USA）
• Abbott Laboratories（USA）
• Thermo Fisher Scientific Inc.（USA）
• Siemens Healthineers AG（Germany）
• F. Hoffmann-La Roche Ltd（Switzerland）
• OraSure Technologies, Inc.（USA）
• Alfa Scientific Designs, Inc.（USA）
• Dragerwerk AG & Co. KGaA（Germany）
• Randox Testing Services（UK）
• United States Drug Testing Laboratories, Inc.（USDTL）（USA）
• Psychemedics Corporation（USA）
• Cordant Health Solutions（USA）
• Omega Laboratories, Inc.（USA）
• Clinical Reference Laboratory, Inc.（USA）
• Premier Biotech, Inc.（USA）
• Danaher Corporation（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Shimadzu Corporation（Japan）
• Lifeloc Technologies, Inc.（USA）

結論和建議

Global Drug Testing Market size was valued at USD 5.9 billion in 2023 and is poised to grow from USD 6.21 billion in 2024 to USD 9.31 billion by 2032, growing at a CAGR of 5.2% during the forecast period (2025-2032).

The drug testing market is poised for significant growth, driven by increasing regulatory demands from government agencies for alcohol and drug testing to address safety concerns. The ongoing efforts to monitor and prevent substance addiction further underscore this trend. Additionally, the global rise in substance misuse, exacerbated by the mental health impact of the COVID-19 pandemic-along with business closures and economic downturns-has heightened the need for comprehensive screening solutions. This includes the detection of both illicit and prescribed medications, as well as performance-enhancing substances used by athletes. As awareness of these issues grows, the demand for drug testing services across various biological samples is expected to surge, presenting ample opportunities for market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Testing Market Segmental Analysis

Global Drug Testing Market is segmented by Product, Sample, Drug, End Use and region. Based on Product, the market is segmented into Consumables, Instruments, Rapid Testing Devices and Services. Based on Sample, the market is segmented into Urine Samples, Oral Fluid Samples, Hair Samples and Other Samples. Based on Drug, the market is segmented into Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD and Others. Based on End Use, the market is segmented into Drug Testing Laboratories, Workplaces, Hospitals and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drug Testing Market

The primary driver propelling the growth of the Global Drug Testing market is the rising rates of drug and alcohol consumption globally. Reports indicate a significant increase in substance abuse, with approximately 275 million individuals aged 15-64 using drugs at least once in 2019, according to the World Drug Report 2021. This troubling trend led to around 36.3 million people grappling with drug dependence, causing substantial health and societal issues, including nearly 500,000 fatalities and the loss of 18 million years of healthy life linked primarily to opioid use. The escalating prevalence of drug and alcohol abuse, notably concerning impaired driving incidents, underscores the urgent need for effective drug testing solutions, thereby driving demand for drug screening products and services, which is expected to significantly enhance overall market growth.

Restraints in the Global Drug Testing Market

The growth of the Global Drug Testing market is expected to be hindered by prohibitions on workplace drug testing in several countries. Nations such as Canada, Colombia, Argentina, Chile, and South Africa view these testing practices as violations of employee privacy. In France, for instance, pre-employment drug testing is only permitted under a physician's prescription. Meanwhile, countries like Poland and the Czech Republic have deemed workplace drug and alcohol testing illegal. Additionally, specific regulations in Eastern Canada allow for such testing solely in high-risk occupational scenarios or select situations. These restrictions in various regions could significantly constrain the overall development and acceptance of drug and alcohol testing in their respective markets.

Market Trends of the Global Drug Testing Market

The Global Drug Testing market is witnessing a significant shift towards innovative, non-invasive solutions, particularly driven by the emergence of fingerprint-based drug testing. Accelerated by the COVID-19 pandemic, this technology offers a hygienic, portable, and rapid alternative to traditional methods, addressing safety concerns associated with viral transmission in clinical settings. As organizations increasingly adopt fingerprint analysis for its ease of use and minimal sample collection requirements, the method demonstrates potential for wider application in workplaces, law enforcement, and rehabilitation programs. This evolving landscape presents substantial growth opportunities for industry players, positioning fingerprint-based tests as a future replacement for conventional urine, hair, and blood tests.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Drug Testing Market Size by Product & CAGR (2025-2032)

• Market Overview
• Consumables
• Instruments
• Rapid Testing Devices
• Services

Global Drug Testing Market Size by Sample & CAGR (2025-2032)

• Market Overview
• Urine Samples
• Oral Fluid Samples
• Hair Samples
• Other Samples

Global Drug Testing Market Size by Drug & CAGR (2025-2032)

• Market Overview
• Alcohol
• Cannabis/Marijuana
• Cocaine
• Opioids
• Amphetamine & Methamphetamine
• LSD
• Others

Global Drug Testing Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Drug Testing Laboratories
• Workplaces
• Hospitals
• Others

Global Drug Testing Market Size & CAGR (2025-2032)

• North America (Product, Sample, Drug, End Use)
  • US
  • Canada
• Europe (Product, Sample, Drug, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Sample, Drug, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Sample, Drug, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Sample, Drug, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Laboratory Corporation of America Holdings (LabCorp) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OraSure Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alfa Scientific Designs, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dragerwerk AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Testing Services (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• United States Drug Testing Laboratories, Inc. (USDTL) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Psychemedics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cordant Health Solutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omega Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinical Reference Laboratory, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Premier Biotech, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifeloc Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations